Bioequivalence and Bioavailability Forum 03:00 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Rock
Junior

India,
2018-02-12 09:47

Posting: # 18407
Views: 576
 

 Body surface area [Regulatives / Guidelines]

Dear Members
Please let me know, if body surface area (BSA) needs to be used for dose calculation in case of non-NTI drugs and in healthy subjects.

Also, confirm if an infusion study with long washout period which anticipated to significant change in weight, results in different dosages across the periods will require dose normalization?
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,698 posts in 3,983 threads, 1,234 registered users;
online 11 (0 registered, 11 guests [including 9 identified bots]).

When puzzled, it never hurts to read the primary documents –
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed